Loading clinical trials...
Loading clinical trials...
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Conditions
Interventions
Oral Treprostinil
Locations
134
United States
The Kirklin Clinic
Birmingham, Alabama, United States
Arizona Pulmonary Specialists, Ltd.
Phoenix, Arizona, United States
Mayo Clinic Phoenix
Phoenix, Arizona, United States
St. Joseph's Hospital and Medical Center
Phoenix, Arizona, United States
University Medical Center
Tucson, Arizona, United States
University of Arizona Clinical and Translational Science (CATS) Research Center
Tucson, Arizona, United States
Start Date
January 16, 2007
Primary Completion Date
February 12, 2020
Completion Date
February 12, 2020
Last Updated
May 10, 2021
NCT07218029
NCT07120789
NCT06649110
NCT04778046
NCT06481852
NCT06477640
Lead Sponsor
United Therapeutics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions